| 000 | 01366 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250518094704.0 | ||
| 264 | 0 | _c20200907 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1471-2377 | ||
| 024 | 7 |
_a10.1186/s12883-020-01702-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeón-Valenzuela, Angel | |
| 245 | 0 | 0 |
_aIncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy - a retrospective case series focusing on dosing and tolerability. _h[electronic resource] |
| 260 |
_bBMC neurology _cApr 2020 |
||
| 300 |
_a126 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aBotulinum Toxins, Type A _xadministration & dosage |
| 650 | 0 | 4 |
_aCerebral Palsy _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle Spasticity _xdrug therapy |
| 650 | 0 | 4 |
_aMuscle Weakness _xchemically induced |
| 650 | 0 | 4 |
_aNeuromuscular Agents _xtherapeutic use |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPalacios, Juan Sánchez | |
| 700 | 1 | _aDel Pino Algarrada, Rogelio | |
| 773 | 0 |
_tBMC neurology _gvol. 20 _gno. 1 _gp. 126 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12883-020-01702-7 _zAvailable from publisher's website |
| 999 |
_c30836209 _d30836209 |
||